$IONQ
IonQ, Inc.

2023 Q1 Form 10-K Financial Statement

#000119312523085558 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $4.285M $3.807M $1.235B
YoY Change 119.41% 131.01% 58737.54%
Cost Of Revenue $1.036M $901.0K $2.891M
YoY Change 82.39% 202.35% 177.98%
Gross Profit $3.249M $2.906M $8.240M
YoY Change 134.58% 115.26% 678.09%
Gross Profit Margin 75.82% 76.33% 0.67%
Selling, General & Admin $13.25M $11.48M $44.35M
YoY Change 19.73% 83.22% 161.35%
% of Gross Profit 407.76% 395.01% 538.24%
Research & Development $16.23M $13.70M $43.98M
YoY Change 121.22% 178.54% 117.41%
% of Gross Profit 499.63% 471.3% 533.71%
Depreciation & Amortization $1.200M $1.356M $4.000M
YoY Change -5.21% 34.93% 56.99%
% of Gross Profit 36.93% 46.66% 48.54%
Operating Expenses $29.48M $26.53M $88.33M
YoY Change 49.89% 117.7% 122.23%
Operating Profit -$28.02M -$23.63M -$85.75M
YoY Change 53.27% 118.0% 121.64%
Interest Expense $4.231M $3.167M $7.093M
YoY Change -266.54%
% of Operating Profit
Other Income/Expense, Net $64.00K $1.811M $6.000K
YoY Change -99.54% -102.86% -100.01%
Pretax Income -$27.34M -$18.65M -$48.51M
YoY Change 546.75% -74.83% -54.32%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$27.34M -$18.65M -$48.51M
YoY Change 546.75% -74.83% -54.32%
Net Earnings / Revenue -637.99% -489.81% -3.93%
Basic Earnings Per Share -$0.14 -$0.25
Diluted Earnings Per Share -$0.14 -$0.09 -$0.25
COMMON SHARES
Basic Shares Outstanding 201.6M 200.0M 197.7M
Diluted Shares Outstanding 200.1M 197.7M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $387.9M $355.8M $355.8M
YoY Change -6.74% -31.9% -31.9%
Cash & Equivalents $51.90M $44.37M $44.37M
Short-Term Investments $336.0M $311.4M $311.4M
Other Short-Term Assets $12.64M $12.54M $12.54M
YoY Change 116.92% 94.64% 94.64%
Inventory
Prepaid Expenses $3.952M
Receivables $1.837M $3.292M $3.292M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $402.3M $371.6M $371.6M
YoY Change -4.73% -29.83% -29.83%
LONG-TERM ASSETS
Property, Plant & Equipment $26.49M $26.01M $29.77M
YoY Change 5.55% 37.86% 29.98%
Goodwill $742.0K $742.0K
YoY Change
Intangibles $10.05M $8.944M
YoY Change 53.12%
Long-Term Investments $137.6M $182.0M $182.0M
YoY Change -19.25% 127.19% 127.19%
Other Assets $4.857M $4.910M $4.910M
YoY Change 42.1% 38.0% 38.0%
Total Long-Term Assets $185.6M $226.4M $226.4M
YoY Change -9.54% 101.37% 101.37%
TOTAL ASSETS
Total Short-Term Assets $402.3M $371.6M $371.6M
Total Long-Term Assets $185.6M $226.4M $226.4M
Total Assets $587.9M $598.0M $598.0M
YoY Change -6.3% -6.86% -6.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.597M $3.055M $3.055M
YoY Change 82.87% 62.33% 62.33%
Accrued Expenses $9.414M $6.655M $6.996M
YoY Change 93.27% 151.42% 178.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $20.86M $20.16M $20.16M
YoY Change 83.22% 108.03% 108.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $77.00K $303.0K $9.621M
YoY Change -99.71% -99.26% -76.6%
Total Long-Term Liabilities $77.00K $303.0K $9.621M
YoY Change -99.71% -99.26% -76.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.86M $20.16M $20.16M
Total Long-Term Liabilities $77.00K $303.0K $9.621M
Total Liabilities $35.69M $29.78M $29.78M
YoY Change -5.26% -41.37% -41.37%
SHAREHOLDERS EQUITY
Retained Earnings -$221.6M -$194.3M
YoY Change 33.27%
Common Stock $20.00K $20.00K
YoY Change 5.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $552.2M $568.2M $568.2M
YoY Change
Total Liabilities & Shareholders Equity $587.9M $598.0M $598.0M
YoY Change -6.3% -6.86% -6.86%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$27.34M -$18.65M -$48.51M
YoY Change 546.75% -74.83% -54.32%
Depreciation, Depletion And Amortization $1.200M $1.356M $4.000M
YoY Change -5.21% 34.93% 56.99%
Cash From Operating Activities -$13.82M -$14.91M -$44.70M
YoY Change 65.97% 218.25% 68.44%
INVESTING ACTIVITIES
Capital Expenditures $1.185M $1.406M $9.336M
YoY Change -142.23% -152.29% -211.1%
Acquisitions
YoY Change
Other Investing Activities $22.82M $6.557M -$298.7M
YoY Change -107.57% -103.21% 45.42%
Cash From Investing Activities $21.32M $5.151M -$309.1M
YoY Change -107.01% -102.49% 44.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 34.00K -1.069M 1.096M
YoY Change -77.03% -104.59% -99.82%
NET CHANGE
Cash From Operating Activities -13.82M -14.91M -44.70M
Cash From Investing Activities 21.32M 5.151M -309.1M
Cash From Financing Activities 34.00K -1.069M 1.096M
Net Change In Cash 7.534M -10.83M -352.7M
YoY Change -102.41% -94.25% -197.18%
FREE CASH FLOW
Cash From Operating Activities -$13.82M -$14.91M -$44.70M
Capital Expenditures $1.185M $1.406M $9.336M
Free Cash Flow -$15.00M -$16.32M -$54.03M
YoY Change 171.84% 717.18% 197.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001824920
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-39694
CY2022 dei Entity Registrant Name
EntityRegistrantName
IONQ, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-2992192
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
4505 Campus Drive
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
College Park
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20740
CY2022 dei City Area Code
CityAreaCode
301
CY2022 dei Local Phone Number
LocalPhoneNumber
298-7997
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
675600000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
201551436
CY2022 dei Auditor Firm
AuditorFirmId
42
CY2022 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2022 dei Auditor Location
AuditorLocation
Tysons, Virginia
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44367000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
399025000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
311430000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
123443000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3292000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
707000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12539000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6442000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
371628000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
529617000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
182001000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
80110000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26014000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18870000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3753000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4032000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8944000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5841000
CY2022Q4 us-gaap Goodwill
Goodwill
742000
CY2021Q4 us-gaap Goodwill
Goodwill
0
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4910000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3558000
CY2022Q4 us-gaap Assets
Assets
597992000
CY2021Q4 us-gaap Assets
Assets
642028000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3055000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1882000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6655000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2647000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
591000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
568000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8729000
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3430000
CY2022Q4 ionq Current Portion Of Stock Option Early Exercise Liabilities
CurrentPortionOfStockOptionEarlyExerciseLiabilities
1130000
CY2021Q4 ionq Current Portion Of Stock Option Early Exercise Liabilities
CurrentPortionOfStockOptionEarlyExerciseLiabilities
1164000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20160000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9691000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3459000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3643000
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1201000
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1533000
CY2022Q4 ionq Stock Option Early Exercise Liabilities Net Of Current Portion
StockOptionEarlyExerciseLiabilitiesNetOfCurrentPortion
839000
CY2021Q4 ionq Stock Option Early Exercise Liabilities Net Of Current Portion
StockOptionEarlyExerciseLiabilitiesNetOfCurrentPortion
1969000
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3819000
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
33962000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
303000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2022Q4 us-gaap Liabilities
Liabilities
29781000
CY2021Q4 us-gaap Liabilities
Liabilities
50798000
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
199862123
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
199862123
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
195630975
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
195630975
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
20000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
19000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
769848000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
737150000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-194302000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-145791000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7355000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-148000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
568211000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
591230000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
597992000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
642028000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11131000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2099000
CY2022 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
2944000
CY2021 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1040000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43978000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20228000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8385000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3233000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35966000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13737000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5604000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2548000
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
96877000
CY2021 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
40786000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-85746000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-38687000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-30136000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
63332000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7093000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
64000
CY2022 ionq Offering Costs Associated With Warrants
OfferingCostsAssociatedWithWarrants
0
CY2021 ionq Offering Costs Associated With Warrants
OfferingCostsAssociatedWithWarrants
4259000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48511000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-106186000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-48511000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-106186000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.77
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.77
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
197727642
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
197727642
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
137609620
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
137609620
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-48511000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-106186000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-7207000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-148000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7207000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-148000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-55718000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-106334000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
53703000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-106186000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-148000
CY2021 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
2381000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
288000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1068000
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
526312000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8023000
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
105789000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
591230000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-48511000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7207000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1059000
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1162000
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
473000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29980000
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
25000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
568211000
CY2022 us-gaap Profit Loss
ProfitLoss
-48511000
CY2021 us-gaap Profit Loss
ProfitLoss
-106186000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5604000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2548000
CY2022 ionq Non Cash Research And Development Arrangements
NonCashResearchAndDevelopmentArrangements
520000
CY2021 ionq Non Cash Research And Development Arrangements
NonCashResearchAndDevelopmentArrangements
1335000
CY2022 ionq Amortization Of Customer Warrant
AmortizationOfCustomerWarrant
0
CY2021 ionq Amortization Of Customer Warrant
AmortizationOfCustomerWarrant
528000
CY2022 ionq Offering Costs Associated With Derivative Warrant Liabilities
OfferingCostsAssociatedWithDerivativeWarrantLiabilities
0
CY2021 ionq Offering Costs Associated With Derivative Warrant Liabilities
OfferingCostsAssociatedWithDerivativeWarrantLiabilities
4259000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
31456000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
7748000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-30136000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
63332000
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1136000
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-101000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1510000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
317000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7012000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3790000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1060000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
763000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1344000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1259000
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3892000
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3605000
CY2022 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
269000
CY2021 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1722000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-44698000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26537000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9336000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7783000
CY2022 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2179000
CY2021 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1621000
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1049000
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
620000
CY2022 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
605689000
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
203761000
CY2022 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
310045000
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0
CY2022 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
848000
CY2021 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-309056000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-213785000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1059000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5457000
CY2022 ionq Receipts Tax Witholding Sharebased Payment Arrangement
ReceiptsTaxWitholdingSharebasedPaymentArrangement
2001000
CY2021 ionq Receipts Tax Witholding Sharebased Payment Arrangement
ReceiptsTaxWitholdingSharebasedPaymentArrangement
0
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1981000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2022 ionq Proceedsfrompublicwarrantsexercised
Proceedsfrompublicwarrantsexercised
17000
CY2021 ionq Proceedsfrompublicwarrantsexercised
Proceedsfrompublicwarrantsexercised
26070000
CY2022 ionq Repurchase Of Early Exercised Stock Options
RepurchaseOfEarlyExercisedStockOptions
0
CY2021 ionq Repurchase Of Early Exercised Stock Options
RepurchaseOfEarlyExercisedStockOptions
968000
CY2022 ionq Proceeds From Merger And Pipe Transaction Net Of Transaction Costs
ProceedsFromMergerAndPipeTransactionNetOfTransactionCosts
0
CY2021 ionq Proceeds From Merger And Pipe Transaction Net Of Transaction Costs
ProceedsFromMergerAndPipeTransactionNetOfTransactionCosts
572668000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1096000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
603227000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-352658000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
362905000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
399025000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36120000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46367000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
399025000
CY2022 ionq Issuance Of Common Stock For Intellectual Property
IssuanceOfCommonStockForIntellectualProperty
0
CY2021 ionq Issuance Of Common Stock For Intellectual Property
IssuanceOfCommonStockForIntellectualProperty
1567000
CY2022 ionq Issuance Of Common Stock For Research And Development Arrangement
IssuanceOfCommonStockForResearchAndDevelopmentArrangement
0
CY2021 ionq Issuance Of Common Stock For Research And Development Arrangement
IssuanceOfCommonStockForResearchAndDevelopmentArrangement
814000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
485000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
553000
CY2022 ionq Intangible Asset Purchases In Accounts Payable And Accrued Expenses
IntangibleAssetPurchasesInAccountsPayableAndAccruedExpenses
164000
CY2021 ionq Intangible Asset Purchases In Accounts Payable And Accrued Expenses
IntangibleAssetPurchasesInAccountsPayableAndAccruedExpenses
83000
CY2022 ionq Non Cash Reclassification Of Warrant Liabilities To Equity Upon Exercise
NonCashReclassificationOfWarrantLiabilitiesToEquityUponExercise
8000
CY2021 ionq Non Cash Reclassification Of Warrant Liabilities To Equity Upon Exercise
NonCashReclassificationOfWarrantLiabilitiesToEquityUponExercise
79719000
CY2022 ionq Bonus Settled In Restricted Stock Units
BonusSettledInRestrictedStockUnits
473000
CY2021 ionq Bonus Settled In Restricted Stock Units
BonusSettledInRestrictedStockUnits
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022 us-gaap Revenues
Revenues
1235000000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of consolidated financial statements in conformity with U.S. GAAP and regulations of the SEC requires management to make estimates and assumptions that affect the amounts reported in these consolidated financial statements and accompanying notes. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Significant estimates and judgments are inherent in the analysis and measurement of items including, but not limited to: revenue recognition, capitalization of internally developed software and quantum computing costs, useful lives of long-lived assets, and fair value of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities. Management bases its estimates and assumptions on historical experience, expectations, forecasts, and on various other factors that are believed to be reasonable under the circumstances. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may differ and be affected by changes in those estimates. </div></div>
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
2000000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44367000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
399025000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
2000000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
0
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46367000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
399025000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3292000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
707000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0
CY2022Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
1300000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2022Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.60
CY2022 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
twelve months
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
4963000
CY2020Q4 us-gaap Deferred Revenue
DeferredRevenue
1358000
CY2022 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
4216000
CY2021 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
200000
CY2022 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
9183000
CY2021 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
3805000
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
9930000
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
4963000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
1300000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
1100000
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentrations of Credit Risk </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"/> <div style="letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, investments, and trade accounts receivable. The Company maintains the majority of its cash, cash equivalents, restricted cash and investments with two financial institutions. The Company’s deposits periodically exceed amounts guaranteed by the Federal Deposit Insurance Corporation. While the Company has not experienced any losses in such accounts, the recent failure of Silicon Valley Bank (“SVB”), at which the Company held cash and cash equivalents in multiple accounts, exposed the Company to limited credit risk prior to the completion by the Federal Deposit Insurance Corporation of the resolution of SVB in a manner that fully protected all depositors. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;text-indent: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s accounts receivable are derived from customers primarily located in the U.S. The Company performs periodic evaluations of its customers’ financial condition and generally does not require its customers to provide collateral or other security to support accounts receivable and maintains an allowance for doubtful accounts. Credit losses historically have not been material. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant customers are those </div> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;">that</div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> represent more than 10% of the Company’s total revenue. </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s revenue was primarily from three significant customers for the year ended December 31, 2022, and from two significant customers for the year ended December 31, 2021. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"> </div>
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-48511000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-106186000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
197727642
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
197727642
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
137609620
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
137609620
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.77
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.77
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42061338
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
36403706
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
547153000
CY2022Q4 us-gaap Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Gain
DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain
42000
CY2022Q4 us-gaap Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Loss
DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss
7397000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
539798000
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
602725000
CY2021Q4 us-gaap Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Gain
DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain
3000
CY2021Q4 us-gaap Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Loss
DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss
150000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
602578000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2022Q4 ionq Debt Securities Available For Sale Contractual Maturity Less Than12 Months
DebtSecuritiesAvailableForSaleContractualMaturityLessThan12Months
355797000
CY2022Q4 ionq Debt Securities Available For Sale Contractual Maturity Greater Than12 Months
DebtSecuritiesAvailableForSaleContractualMaturityGreaterThan12Months
184001000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
539798000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33475000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22315000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7461000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3445000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26014000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18870000
CY2022 us-gaap Depreciation
Depreciation
4000000
CY2021 us-gaap Depreciation
Depreciation
1700000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11655000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-2711000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8944000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6985000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-1144000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5841000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1600000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2130000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1646000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
744000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
124000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
124000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
4045000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8813000
CY2022Q4 ionq Percentage Of Common Stock Holding
PercentageOfCommonStockHolding
0.005
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4935000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
152000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
119000
CY2022Q4 ionq Deferred Tax Assets Warrant Expense
DeferredTaxAssetsWarrantExpense
149000
CY2021Q4 ionq Deferred Tax Assets Warrant Expense
DeferredTaxAssetsWarrantExpense
138000
CY2022Q4 ionq Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
2725000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1025000
CY2022Q4 ionq Accrued Accounting And Taxes Current
AccruedAccountingAndTaxesCurrent
250000
CY2021Q4 ionq Accrued Accounting And Taxes Current
AccruedAccountingAndTaxesCurrent
700000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1470000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
922000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6655000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2647000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one vote per share
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
67018583
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
67256430
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
8301202
CY2020Q3 ionq Percent Of Warrant Shares Will Vest And Be Immediately Exercisable
PercentOfWarrantSharesWillVestAndBeImmediatelyExercisable
0.065
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.38
CY2019Q4 ionq Fair Value Of The Warrant Shares
FairValueOfTheWarrantShares
8700000
CY2020Q4 ionq Fair Value Of Warrants Vested
FairValueOfWarrantsVested
600000
CY2021 ionq Warrant Amortization
WarrantAmortization
500000
CY2022 ionq Warrant Amortization
WarrantAmortization
0
CY2022Q4 ionq Class Of Warrant Or Right Issue Price
ClassOfWarrantOrRightIssuePrice
11.5
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
49690000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1002000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.026
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0096
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M25D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M3D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7582
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7704
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
22133210
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.64
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M2D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
377580000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4974350
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.28
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2239490
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.47
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
151800
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.66
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
24716270
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.19
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M25D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
49690000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
11484369
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.85
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y6M
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
31490000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
24716270
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
2.19
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y3M25D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6700000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
54400000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
9900000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
7400000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.58
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.83
CY2022Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
905128
CY2021Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
1420662
CY2022Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
2000000
CY2021Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
3100000
CY2021 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
400000
CY2021 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
1000000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33197000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8023000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.074
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.012
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.059
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.017
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.051
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.006
CY2022 ionq Effective Income Tax Rate Reconciliation Warrant Expense
EffectiveIncomeTaxRateReconciliationWarrantExpense
0.13
CY2021 ionq Effective Income Tax Rate Reconciliation Warrant Expense
EffectiveIncomeTaxRateReconciliationWarrantExpense
-0.125
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.004
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.021
CY2022 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.109
CY2021 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.534
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.081
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.001
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.006
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q4 ionq Deferred Tax Assets Accrued Bonus
DeferredTaxAssetsAccruedBonus
1018000
CY2021Q4 ionq Deferred Tax Assets Accrued Bonus
DeferredTaxAssetsAccruedBonus
310000
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
0
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
281000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2965000
CY2021Q4 ionq Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
170000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1955000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
809000
CY2022Q4 ionq Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
1068000
CY2021Q4 ionq Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
1023000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6240000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3781000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
24836000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14148000
CY2022Q4 ionq Deferred Tax Assets Capitalized Research And Development Expense
DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense
8262000
CY2021Q4 ionq Deferred Tax Assets Capitalized Research And Development Expense
DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense
0
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
49370000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
21781000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
48212000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20388000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1158000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1393000
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
989000
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
979000
CY2022Q4 ionq Capitalized Research And Development Expense
CapitalizedResearchAndDevelopmentExpense
0
CY2021Q4 ionq Capitalized Research And Development Expense
CapitalizedResearchAndDevelopmentExpense
414000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
169000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1158000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1393000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20388000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9747000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
25925000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
10677000
CY2022 ionq Deferred Tax Assets Tax Deferred Income Expense Other
DeferredTaxAssetsTaxDeferredIncomeExpenseOther
1899000
CY2021 ionq Deferred Tax Assets Tax Deferred Income Expense Other
DeferredTaxAssetsTaxDeferredIncomeExpenseOther
-36000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
48212000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20388000
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1100000
CY2022Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
6300000
CY2022Q4 ionq Percentage Of Stock Owned By Shareholder
PercentageOfStockOwnedByShareholder
0.05
CY2022 ionq Percentage Of Increase Of Stock Owned By Shareholder
PercentageOfIncreaseOfStockOwnedByShareholder
0.50
CY2022 ionq Testing Period In Which Shareholding Increase By Shareholder Considered
TestingPeriodInWhichShareholdingIncreaseByShareholderConsidered
P3Y
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
27800000
CY2022 ionq Years Of Statute Of Limitations By Major Tax Jurisdictions
YearsOfStatuteOfLimitationsByMajorTaxJurisdictions
P3Y
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.119
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.119
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
763000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
763000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
79000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
13000
CY2022 us-gaap Lease Cost
LeaseCost
842000
CY2021 us-gaap Lease Cost
LeaseCost
776000
CY2022 us-gaap Lease Cost
LeaseCost
842000
CY2021 us-gaap Lease Cost
LeaseCost
776000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
644000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
561000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
671000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
750000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
772000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
795000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
819000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2532000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6339000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2289000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4050000
CY2022 ionq Lessee Operating Lease Expiration Year
LesseeOperatingLeaseExpirationYear
2030
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
9700000
CY2022 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
1
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
900000
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
500000
CY2022 ionq Related Party Transaction Term
RelatedPartyTransactionTerm
P3Y
CY2021 ionq Allocated Rent Expense
AllocatedRentExpense
600000
CY2022 ionq Allocated Rent Expense
AllocatedRentExpense
600000

Files In Submission

Name View Source Status
0001193125-23-085558-index-headers.html Edgar Link pending
0001193125-23-085558-index.html Edgar Link pending
0001193125-23-085558.txt Edgar Link pending
0001193125-23-085558-xbrl.zip Edgar Link pending
d424437d10k.htm Edgar Link pending
d424437dex1014.htm Edgar Link pending
d424437dex1030.htm Edgar Link pending
d424437dex231.htm Edgar Link pending
d424437dex311.htm Edgar Link pending
d424437dex312.htm Edgar Link pending
d424437dex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ionq-20221231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
ionq-20221231_def.xml Edgar Link unprocessable
ionq-20221231_lab.xml Edgar Link unprocessable
ionq-20221231_pre.xml Edgar Link unprocessable
d424437d10k_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ionq-20221231_cal.xml Edgar Link unprocessable